I am pretty sure that the FDA has definitions of "substantial" and "relevant" in connection with issuing BTD so that they are not vague.
If I recall correctly our improvement was NOT substantial over the current SOC which changed in the middle of our submission.
(1)
(1)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-